Severe COVID-19 patients at greater risk of post-infection symptoms: ECDC
Individuals who are severely affected by COVID-19 may be at higher risk of post-infection symptoms, the European Center for Disease Prevention and Control (ECDC) said on Monday.
In its latest report, ECDC said that "post-COVID-19 symptoms appear to be more prevalent among patients from hospital settings when compared to community settings."
According to the report, a wide range of physical and psychological symptoms have been reported by individuals at least 12 weeks following a SARS-CoV-2 infection.
Five post-COVID-19 symptoms - fatigue, shortness of breath, depression, headache and dizziness - were found to be more prevalent among patients from hospital settings than those from community settings.
The report is based on studies conducted in the European Economic Area, the UK, the US, Canada, Australia and New Zealand. It may assist policymakers and public health authorities in estimating the burden of the post-COVID-19 condition, and support the planning of rehabilitation services during the post-acute phase of the pandemic.
However, ECDC also emphasized that estimates regarding the prevalence of symptoms must be interpreted with caution, as most of the studies lacked comparisons with groups of non-infected people.
The agency stressed that there are still many unknown factors in terms of current and future risks to populations for post-COVID-19 condition, in the context of increased levels of vaccination and hybrid immunity.
In its latest report, ECDC said that "post-COVID-19 symptoms appear to be more prevalent among patients from hospital settings when compared to community settings."
According to the report, a wide range of physical and psychological symptoms have been reported by individuals at least 12 weeks following a SARS-CoV-2 infection.
Five post-COVID-19 symptoms - fatigue, shortness of breath, depression, headache and dizziness - were found to be more prevalent among patients from hospital settings than those from community settings.
The report is based on studies conducted in the European Economic Area, the UK, the US, Canada, Australia and New Zealand. It may assist policymakers and public health authorities in estimating the burden of the post-COVID-19 condition, and support the planning of rehabilitation services during the post-acute phase of the pandemic.
However, ECDC also emphasized that estimates regarding the prevalence of symptoms must be interpreted with caution, as most of the studies lacked comparisons with groups of non-infected people.
The agency stressed that there are still many unknown factors in terms of current and future risks to populations for post-COVID-19 condition, in the context of increased levels of vaccination and hybrid immunity.
RELATED ARTICLES
